The life sciences sector has emerged as a significant driver of innovation and economic growth in recent years.
With advancements in biotechnology, pharmaceuticals, medical devices and healthcare services, the life sciences industry is improving human health and transforming the landscape of commercial real estate.
Our Life Sciences and Commercial Property team look at how the life sciences are reshaping commercial property markets and the unique requirements and opportunities the sector brings.
The Rise of Life Sciences
Life sciences encompass various disciplines focused on understanding and improving living organisms’ health and well-being.
It is also at the forefront of scientific and medical advancements. Several factors have fuelled the growth of the life sciences industry, including:
- Technological innovation – technological advances, such as AI-driven drug discovery, have accelerated research and development.
- Ageing population – the increasing global population of elderly individuals drives demand for new treatments and healthcare solutions.
- Pandemic response – COVID-19 underscored the importance of robust life sciences infrastructure for vaccine development and public health management.
Life Sciences and Commercial Real Estate
The growth of life sciences has significant implications for the commercial real estate sector and is influencing the property market in several ways:
- Life sciences companies require specialised facilities to conduct research, development and manufacturing, often including wet labs, clean rooms and pilot plants.
- Certain location preferences exist, and proximity to academic institutions, hospitals and other research organisations is crucial for life sciences companies.
- The high demand for life sciences space has led to the adaptive reuse of existing commercial properties.
Converting traditional office buildings, warehouses, and retail spaces into life sciences facilities is a growing trend.
This approach meets the sector’s needs and revitalises underutilised properties.
Investment opportunities
The crossover between life sciences and commercial real estate presents lucrative investment opportunities, with real estate investors increasingly targeting life sciences properties due to their strong demand and growth potential.
Some key considerations for investors include:
- Long-term leases – life sciences companies often sign long-term commercial leases due to the complexity and cost of setting up specialised facilities.
- Tenant covenant strength – many life sciences firms, especially those backed by venture capital or with successful product pipelines, are financially stable and reliable tenants.
- Infrastructure requirements – understanding the unique infrastructure needs of life sciences is critical for successful investment and property management.
Challenges and considerations
While the life sciences sector offers exciting opportunities, it also presents challenges for commercial real estate.
Building or converting spaces to meet the stringent requirements of life sciences can incur high initial costs.
Further, life sciences facilities must comply with strict regulatory standards, requiring careful planning and execution.
Finally, the life sciences sector is highly dynamic, with rapid technological advancements and evolving market demands necessitating flexible and adaptable real estate solutions.
The convergence of life sciences and commercial real estate is a testament to the transformative power of scientific advancement.
As the life sciences sector grows, it will undoubtedly reshape the commercial property landscape, offering unique opportunities and challenges.
Contact Our Life Sciences Solicitors
If you have any questions or would like more information regarding commercial property for the Life Sciences sector and how this may affect your business, please contact our Life Science Solicitors, who would be happy to assist.
Call us on:
01619414000
More Life Science News
Research & Development Agreements: Key Legal and Commercial Issues
Research and Development (R&D) Agreements play a key role in enabling organisations to pool expertise and resources to develop new products or processes. Agreements of this nature are commonly used between commercial entities and academic institutions, and play a key role in establishing the funding models under which research takes place. With...
Read Blog
Life Sciences in the UK – An End of Year Update for 2024
In this blog, our Life Science Solicitors consider the state of play for the Life Sciences sector in the UK as 2024 draws to a close by providing an update on developments regarding the schemes and initiatives we have discussed throughout the year.
Read Blog
Opportunities and Challenges of Using AI In Medical Research
The Government has recently announced its plans to invest £6.4 million in an Artificial Intelligence (AI) digital pathology data platform , with the particular aim of (1) storing digital pathology data from the NHS and (2) training AI models on this set of information to help improve the identification and treatment of diseases. The programme is...
Read Blog
Employment Status in the Life Sciences Sector: A New Dawn
In recent years, working models have become increasingly varied, with organisations routinely departing from traditional employee/employer arrangements. This is particularly the case for the life sciences industry, which, given the work's project-driven nature, has historically relied upon consultant and contractor staff. Our Life Sciences and...
Read Blog
Life Sciences and Commercial Real Estate: A Growing Synergy
The life sciences sector has emerged as a significant driver of innovation and economic growth in recent years. With advancements in biotechnology, pharmaceuticals, medical devices and healthcare services, the life sciences industry is improving human health and transforming the landscape of commercial real estate. Our Life Sciences and...
Read Blog
Carrying Out Legal Due Diligence in the Life Sciences Sector
Due diligence is essential to any business (or company) purchase, particularly in the life sciences sector. It allows the buyer to obtain information relating to the business to manage the risk caused by the buyer-beware principle. The due diligence process begins at the start of the transaction and is likely to continue throughout the...
Read Blog
Sarah Dabek
Senior Associate
Sarah is a Senior Associate in the Real Estate team at Myerson and has been with the firm since beginning her training contract in 2016, subsequently qualifying into the Real Estate team in 2018 and achieving promotions to Associate in 2021 and Senior Associate in 2024.
About Sarah Dabek